MedPath

HAVAH THERAPEUTICS PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:2

Trial Phases

2 Phases

Phase 1:2
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (66.7%)
Phase 2
1 (33.3%)

A Single Dose Trial to Evaluate the Pharmacokinetics of Testosterone and Anastrozole

Phase 1
Completed
Conditions
Mammographic Density
Interventions
First Posted Date
2017-10-19
Last Posted Date
2018-04-18
Lead Sponsor
Havah Therapeutics Pty Ltd
Target Recruit Count
11
Registration Number
NCT03314298
Locations
🇦🇺

Wellend Health, Toorak Gardens, South Australia, Australia

Enobosarm and Anastrozole in Pre-menopausal Women With High Mammographic Breast Density

Phase 1
Completed
Conditions
Mammographic Density
Interventions
First Posted Date
2017-08-29
Last Posted Date
2018-04-18
Lead Sponsor
Havah Therapeutics Pty Ltd
Target Recruit Count
9
Registration Number
NCT03264651
Locations
🇦🇺

Wellend Health, Toorak Gardens, South Australia, Australia

Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-Effects

Phase 2
Conditions
Breast Cancer
Arthralgia
Osteoporosis
Interventions
First Posted Date
2007-07-06
Last Posted Date
2009-04-09
Lead Sponsor
Havah Therapeutics Pty Ltd
Target Recruit Count
90
Registration Number
NCT00497458
Locations
🇦🇺

Burnside Breast Centre, Adelaide, South Australia, Australia

News

No news found
© Copyright 2025. All Rights Reserved by MedPath